Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AdaptHealth (AHCO) Income from Non-Controlling Interests (2019 - 2025)

AdaptHealth (AHCO) has 7 years of Income from Non-Controlling Interests data on record, last reported at $1.1 million in Q1 2025.

  • For Q1 2025, Income from Non-Controlling Interests rose 10.05% year-over-year to $1.1 million; the TTM value through Mar 2025 reached $4.3 million, up 4.15%, while the annual FY2023 figure was $4.1 million, 7.81% up from the prior year.
  • Income from Non-Controlling Interests reached $1.1 million in Q1 2025 per AHCO's latest filing, up from $1.1 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $1.2 million in Q2 2022 and bottomed at $174000.0 in Q3 2021.
  • Average Income from Non-Controlling Interests over 5 years is $890937.5, with a median of $1.0 million recorded in 2022.
  • Peak YoY movement for Income from Non-Controlling Interests: crashed 71.93% in 2021, then soared 535.06% in 2022.
  • A 5-year view of Income from Non-Controlling Interests shows it stood at $529000.0 in 2021, then skyrocketed by 92.25% to $1.0 million in 2022, then dropped by 8.75% to $928000.0 in 2023, then grew by 18.1% to $1.1 million in 2024, then increased by 2.92% to $1.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Non-Controlling Interests were $1.1 million in Q1 2025, $1.1 million in Q3 2024, and $1.1 million in Q2 2024.